K. Humaloja et al., EFFECTS OF TRITON WR-1339 AND OROTIC-ACID ON BILIARY AND SERUM DOLICHOLS IN RATS, Metabolism, clinical and experimental, 47(6), 1998, pp. 644-649
Two lysosomal storage diseases, aspartylglucosaminuria and mannosidosi
s, are associated with highly elevated serum dolichol concentrations.
To eludicate possible mechanisms leading to elevated serum dolichols,
we studied the effects of Triton WR 1339 (known to increase serum chol
esterol) and erotic acid (known to decrease serum cholesterol) on bloo
d and biliary dolichol and beta hexosaminidase levels in rats. In Trit
on WR 1339-treated rats, serum dolichol was markedly increased compare
d with saline-treated controls 1 (400 +/- 70 ng/mL, n = 7 v 85 +/- 11
ng/mL, n = 8, P < .001), 4(789 +/- 70 ng/mL, n = 10 v 110 +/- 10 ng/mL
, n = 7, P < .0001), and 8 (549 +/- 43 ng/mL, n = 8 v 87 +/- 8 ng/mL,
n = 7, P < .001) days after administration of the drug. By contrast, s
erum dolichol was decreased (64 +/- 5 ng/mL, n = 8 v 119 +/- 7 ng/mL,
n = 8, P < .0001) after a 7-day erotic acid feeding compared with cont
rols. Serum beta-hexosaminidase was unaffected by both treatments. Oro
tic acid also increased biliary dolichol (280 +/- 47 ng/100 g body wei
ght [BW]/h, n = 7 v 83 +/- 15 ng/100 g BW/h, n = 7, P < .01) and beta-
hexosaminidase (21 +/- 3 mU/100 g BW/h, n = 7 v 8.3 +/- 2 mU/100 g BW/
h, n = 9, P < .01) excretion compared with controls. Thus, both Triton
WR 1339 and erotic acid have an effect on dolichol metabolism, and it
is conceivable-based on our results-that serum dolichol concentration
s are regulated, at least in part, by a mechanism similar to that for
serum cholesterol levels. Copyright (C) 1998 by W.B. Saunders Company.